The Cancer Grand Challenges initiative is set to receive a significant funding boost through a strategic partnership between the French Institut National Du Cancer (INCa) in Boulogne-Billancourt, France, and Cancer Research UK based in London. This collaboration aims to enhance financial support for the initiative by providing an additional €10 million (£8·6 million) for the upcoming round of winning bids, scheduled to be announced in March 2024.
Bruno Quesnel, a representative from INCa, emphasized the need for substantial investments to achieve groundbreaking advancements in cancer treatment. Over the past three decades, progress in cancer treatments has been gradual, and Quesnel emphasized the necessity for a more disruptive approach. He highlighted the essential elements for success, including large-scale investments, the utilization of extensive data, interdisciplinary methodologies, and collaborative efforts among leading experts in the field.
Quesnel praised the well-designed strategy of the Cancer Grand Challenges initiative, emphasizing its focus on prioritizing scientific contributions and input from investigators. He noted that the initiative has already proven its ability to attract and coordinate efforts from some of the most prominent cancer research agencies. With INCa’s ten-year cancer research strategy in place, Quesnel expressed confidence that the collaboration with Cancer Grand Challenges will significantly contribute to the realization of their overarching goals in cancer research.
Read the full text here.
References
- Wilkinson, E. (2023). UK and France form partnership to tackle greatest challenges in cancer. Lancet Oncology, 24(11), 1172. https://doi.org/10.1016/s1470-2045(23)00509-0
Disclaimers
- The material in these reviews is from various public open-access sources, meant for educational and informational purposes only
- Any personal opinions expressed are those of only the author(s) and are not intended to represent the position of any organization(s)
- No official support by any organization(s) has been provided or should be inferred